Published in Pharma Law Weekly, January 16th, 2007
This trend article about Kyoto Prefectural University of Medicine, Japan, is an immediate alert from NewsRx to identify developing directions of research.
"SFN, a naturally occurring isothiocyanate, is an attractive agent because of its potent anticancer effects. SFN suppresses the proliferation of various cancer cells in vitro and in vivo. TRAIL is also one of the most promising candidates for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.